Szanto T - Search Results

1

Phenotypic and genotypic characterization of 10 Finnish patients with von Willebrand disease type 3: discovery of two main mutations.

Jokela V, Lassila R, Szanto T, Joutsi-Korhonen L, Armstrong E, Oyen F, Schneppenheim S, Schneppenheim R. Jokela V, et al. Among authors: szanto t. Haemophilia. 2013 Nov;19(6):e344-8. doi: 10.1111/hae.12225. Epub 2013 Jul 9. Haemophilia. 2013. PMID: 23834637

2

Management of acute myocardial infarction in a patient with factor XIII deficiency using prophylactic factor replacement therapy.

Szántó T, Salmela B, Mäkipernaa A, Armstrong E, Lassila R. Szántó T, et al. Haemophilia. 2008 Jan;14(1):163-5. doi: 10.1111/j.1365-2516.2007.01559.x. Epub 2007 Oct 24. Haemophilia. 2008. PMID: 17961171 No abstract available.

3

Enhanced thrombin formation and fibrinolysis during acute Puumala hantavirus infection.

Laine O, Mäkelä S, Mustonen J, Huhtala H, Szanto T, Vaheri A, Lassila R, Joutsi-Korhonen L. Laine O, et al. Among authors: szanto t. Thromb Res. 2010 Aug;126(2):154-8. doi: 10.1016/j.thromres.2010.05.025. Epub 2010 Jul 1. Thromb Res. 2010. PMID: 20579693

4

New insights into von Willebrand disease and platelet function.

Szántó T, Joutsi-Korhonen L, Deckmyn H, Lassila R. Szántó T, et al. Semin Thromb Hemost. 2012 Feb;38(1):55-63. doi: 10.1055/s-0031-1300952. Epub 2012 Feb 7. Semin Thromb Hemost. 2012. PMID: 22314604 Review.

5

Comprehensive re-evaluation of historical von Willebrand disease diagnosis in association with whole blood platelet aggregation and function.

Nummi V, Lassila R, Joutsi-Korhonen L, Armstrong E, Szanto T. Nummi V, et al. Among authors: szanto t. Int J Lab Hematol. 2018 Jun;40(3):304-311. doi: 10.1111/ijlh.12785. Epub 2018 Feb 10. Int J Lab Hematol. 2018. PMID: 29427305

6

Fifth Åland Island conference on von Willebrand disease.

Berntorp E, Ågren A, Aledort L, Blombäck M, Cnossen MH, Croteau SE, von Depka M, Federici AB, Goodeve A, Goudemand J, Mannucci PM, Mourik M, Önundarson PT, Rodeghiero F, Szántó T, Windyga J. Berntorp E, et al. Among authors: szanto t. Haemophilia. 2018 May;24 Suppl 4:5-19. doi: 10.1111/hae.13475. Haemophilia. 2018. PMID: 29687935 Free article.

7

Evaluation of a standardized protocol for thrombin generation using the calibrated automated thrombogram: A Nordic study.

Ljungkvist M, Strandberg K, Berntorp E, Chaireti R, Holme PA, Larsen OH, Lassila R, Jouppila A, Szanto T, Zetterberg E. Ljungkvist M, et al. Among authors: szanto t. Haemophilia. 2019 Mar;25(2):334-342. doi: 10.1111/hae.13640. Epub 2019 Feb 4. Haemophilia. 2019. PMID: 30715788

8

Platelets compensate for poor thrombin generation in type 3 von Willebrand disease.

Szanto T, Nummi V, Jouppila A, Brinkman HJM, Lassila R. Szanto T, et al. Platelets. 2020;31(1):103-111. doi: 10.1080/09537104.2019.1581922. Epub 2019 Mar 5. Platelets. 2020. PMID: 30836803

9

Intravenous immunoglobulin treatment in a type 3 von Willebrand disease patient with alloantibodies and a life-threatening gastrointestinal bleed.

Nummi V, Lehtinen E, Mäkipernaa A, Szanto T, Lassila R. Nummi V, et al. Among authors: szanto t. Haemophilia. 2019 Jul;25(4):e291-e293. doi: 10.1111/hae.13765. Epub 2019 May 2. Haemophilia. 2019. PMID: 31050121 No abstract available.

10

Continuous intravenous infusion of enoxaparin controls thrombin formation more than standard subcutaneous administration in critically ill patients. A sub-study of the ENOKSI thromboprophylaxis RCT.

Vahtera A, Szanto T, Lassila R, Valkonen M, Sivula M, Huhtala H, Pettilä V, Kuitunen A. Vahtera A, et al. Among authors: szanto t. Acta Anaesthesiol Scand. 2021 Jan;65(1):109-115. doi: 10.1111/aas.13697. Epub 2020 Sep 16. Acta Anaesthesiol Scand. 2021. PMID: 32888192 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

66 results

Search Page